New insulin survives warmth
A young Monash University chemist and her colleagues have successfully strengthened insulin's chemical structure without affecting its activity. Their new insulin won't require refrigeration.
At the same time they're using their new knowledge to develop a form of insulin that could be delivered by pill.
"Over two hundred million people need insulin to manage diabetes, but we still don't how it works at a molecular level," says Bianca van Lierop.
Her work will be presented for the first time in public this week at Fresh Science, a communication boot camp for early career scientists held at the Melbourne Museum. Bianca is one of 16 winners from across Australia.
The poor stability of existing forms of insulin complicates the management of diabetes, a condition which already affects 1.7 million Australians.
"Like milk, insulin formulations need to be kept cold," Bianca says.
"At temperatures above 4 ºC, insulin starts to degrade and eventually becomes inactive. So supplying insulin in areas where fridges are scarce or difficult to maintain presents a real challenge."
The instability of insulin is closely related to its chemical structure, Bianca says.
"Insulin is constructed from two different protein chains which are joined together by unstable disulfide bonds. Using a series of chemical reactions, we have been able to replace the unstable bonds with stronger, carbon-based bridges. This replacement does not change the natural activity of insulin, but it does appear to significantly enhance its stability."
These so-called 'dicarba insulins' are stable at room temperature. And, Bianca says, storage at higher temperatures for several years had not resulted in degradation or loss of activity.
The new insulins may also provide much-needed insight into how the molecule works. "Insulin acts like a key in a lock at its receptor. When insulin binds to the receptor the lock opens and allows sugar to be taken up into cells from the blood. But insulin is known to change shape inside the 'lock' (the receptor), and its final shape is currently unknown.
"If we had that information, we might be able to design smaller, less complex, non-protein mimics of insulin." Such molecules could one day become the basis of treatments taken in pill form, eliminating the need for injections.
Bianca van Lierop and her fellow Fresh Scientists are presenting their research to the public for the first time thanks to Fresh Science, a national program sponsored by the Australian Government.
Source: Fresh Science
Have your say...
The approval of your comment is at the discretion of this article's publisher. Write your comment with the following in mind to ensure the highest likelihood of it being approved:
- No promotional undertones
- No use of profanity
- Good spelling, grammar and layout
- Check punctuation, language and missing words
- No use of aggression
- No unsubstantiated claims
We reserve the right to remove comments at our discretion.
Your name is used alongside Comments.